# Thomas, McNerney & Partners: portfolio, investments and team

> Thomas, McNerney & Partners is a vc firm based in United States. 33 investments on record, latest Oct 2014. Portfolio, stages, co-investors and team.

Source: https://millionrounds.com/fund/thomas-mcnerney-and-partners (Millionrounds; every figure on the page links to its filing or article)

United States · [Investor](https://millionrounds.com/investors)

# Thomas, McNerney & Partners

Last cheque observed Oct 2014. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

Quiet VC firm Website unconfirmed

Growth Pre-seed Seed Consumer FinTech Finance & Crypto

Cheques on record

**0%** of best year **0** **cheques in 12 months**, 33 on record

Since the last cheque **4396** days **00** hrs **00** min **00** sec

Median round **$17M** Rounds led **0 of 33** Sole investor **2 rounds** Exits **6 from the portfolio** Mostly in **United States, 100%**

Pitch Thomas, McNerney & Partners

## Thomas, McNerney & Partners highlights

- 01 33 rounds on record
- 02 Mostly Venture and Series B: 47% of its rounds
- 03 Sole investor in 2 rounds, median $15M
- 04 6 exits from the portfolio

## What they do

- **Type:** VC firm (from a list, unverified)
- **Cheque size:** Not stated
- **Stages:** Growth Pre-seed Seed Series A Series B
- **Sectors:** Consumer FinTech Finance & Crypto
- **Based in:** Stamford, United States
- **Cold pitches:** Not stated

A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. [Tell us the right one](https://millionrounds.com/corrections?slug=thomas-mcnerney-and-partners).

## The record

Every round we can evidence, newest first **33 appearances**

- **2014** 2 rounds
- **Oct** **[Invitae](https://millionrounds.com/company/invitae)** Series F · US **$120M** With 13 others
- **Jan** **[Auspex Pharmaceuticals](https://millionrounds.com/company/auspex-pharmaceuticals)** Series E · US · sec.gov **$20M** With 4 others
- **2013** 1 round
- **Jan** **[AxioMed Spine](https://millionrounds.com/company/axiomed-spine)** Series D · US · finsmes.com **$3.6M** With 4 others
- **2012** 5 rounds
- **Nov** **[Auspex Pharmaceuticals](https://millionrounds.com/company/auspex-pharmaceuticals)** Series D · US · in.finance.yahoo.com **$25M** With 3 others
- **Oct** **[Cebix](https://millionrounds.com/company/cebix)** Series C · US · pehub.com **$31M** With 2 others
- **Sept** **[Torax Medical](https://millionrounds.com/company/torax-medical)** Series D · US · finsmes.com **$30M** With 5 others
- **Apr** **[Tioga Pharmaceuticals](https://millionrounds.com/company/tioga-pharmaceuticals)** Series B · US · tiogapharma.com **$10M** With 1 other
- **Jan** **[SGB](https://millionrounds.com/company/sgb)** Series B · US · businessreel.com **$17M** With 3 others
- **2011** 2 rounds
- **Dec** **[InnoPharma](https://millionrounds.com/company/innopharma)** Series A · US · finsmes.com **$15M** Sole investor
- **Jun** **[CAS Medical Systems](https://millionrounds.com/company/cas-medical-systems)** Venture · US · devicespace.com **$15M** Sole investor
- **2010** 8 rounds
- **Oct** **[AxioMed Spine](https://millionrounds.com/company/axiomed-spine)** Series D · US · onbiovc.com **$15M** With 6 others
- **Oct** **[Auspex Pharmaceuticals](https://millionrounds.com/company/auspex-pharmaceuticals)** Series C · US · onbiovc.com **$12M** With 2 others
- **Sept** **[Celator Pharmaceuticals](https://millionrounds.com/company/celator-pharmaceuticals)** Series D · US · celatorpharma.com **$20M** With 6 others
- **Sept** **[Cebix](https://millionrounds.com/company/cebix)** Venture · US · xconomy.com **$16M** With 2 others
- **Jul** **[Zogenix](https://millionrounds.com/company/zogenix)** Venture · US · zogenix.com **$15M** With 4 others
- **May** **[NeuroTherapeutics Pharma](https://millionrounds.com/company/neurotherapeutics-pharma)** Series B · US · fiercebiotech.com **$43M** With 4 others
- **Feb** **[Altair Therapeutics](https://millionrounds.com/company/altair-therapeutics)** Series B · US · onbiovc.com **$17M** With 3 others
- **Jan** **[Intuity Medical](https://millionrounds.com/company/intuity-medical)** Series D · US · finsmes.com **$64M** With 5 others
- **2009** 2 rounds
- **Nov** **[Virdante Pharmaceuticals](https://millionrounds.com/company/virdante-pharmaceuticals)** Series A · US · onbiovc.com **$30M** With 6 others
- **Oct** **[Quinnova Pharmaceuticals](https://millionrounds.com/company/quinnova-pharmaceuticals)** Series B · US · onbiovc.com **$17M** With 2 others
- **2007** 3 rounds
- **Nov** **[Clarus Therapeutics](https://millionrounds.com/company/clarus-therapeutics)** Series C · US **$8.0M** With 1 other
- **Nov** **[Tranzyme](https://millionrounds.com/company/tranzyme)** Venture · US **$20M** With 3 others
- **Aug** **[Leptos Biomedical](https://millionrounds.com/company/leptos-biomedical)** Series C · US **$20M** With 3 others
- **2006** 5 rounds
- **Dec** **[Softscope Medical Technologies](https://millionrounds.com/company/softscope-medical-technologies)** Series A · US **$4.0M** With 1 other
- **Dec** **[Galil Medical](https://millionrounds.com/company/galil-medical)** Venture · US · galil-medical.com **$52M** With 2 others
- **Nov** **[Quinnova Pharmaceuticals](https://millionrounds.com/company/quinnova-pharmaceuticals)** Series A · US **$14M** With 1 other
- **Nov** **[Solstice Neurosciences](https://millionrounds.com/company/solstice-neurosciences)** Series B · US · solsticeneuro.com **$85M** With 4 others
- **Aug** **[Zogenix](https://millionrounds.com/company/zogenix)** Series A · US · zogenix.com **$60M** With 4 others
- **2005** 3 rounds
- **Jul** **[Solstice Neurosciences](https://millionrounds.com/company/solstice-neurosciences)** Venture · US **$8.0M** With 3 others
- **Jun** **[Torax Medical](https://millionrounds.com/company/torax-medical)** Series B · US · bizjournals.com **$10M** With 2 others
- **May** **[Tranzyme](https://millionrounds.com/company/tranzyme)** Series A · US **Undisclosed** With 6 others
- **2003** 2 rounds
- **Oct** **[OsteoBiologics](https://millionrounds.com/company/osteobiologics)** Venture · US **$9.2M** With 2 others
- **Aug** **[Coley Pharmaceutical Group](https://millionrounds.com/company/coley-pharmaceutical-group)** Venture · US **$30M** With 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

We hold **2** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## Exits from the portfolio

Companies it backed that were later bought or listed **6 in all**

**[Auspex Pharmaceuticals](https://millionrounds.com/company/auspex-pharmaceuticals)** Bought by [Teva Pharmaceutical Industries](https://millionrounds.com/fund/teva-pharmaceutical-industries) **$3.2B** Mar 2015

**[InnoPharma](https://millionrounds.com/company/innopharma)** Bought by [Pfizer](https://millionrounds.com/fund/pfizer) **$225M** Jul 2014

**[Zogenix](https://millionrounds.com/company/zogenix)** Listed **Undisclosed** Nov 2010

**[Solstice Neurosciences](https://millionrounds.com/company/solstice-neurosciences)** Bought by US WorldMeds **$36M** Aug 2010

**[Coley Pharmaceutical Group](https://millionrounds.com/company/coley-pharmaceutical-group)** Bought by [Pfizer](https://millionrounds.com/fund/pfizer) **Undisclosed** Nov 2007

**[OsteoBiologics](https://millionrounds.com/company/osteobiologics)** Bought by [Smith & Nephew](https://millionrounds.com/fund/smith-and-nephew) **Undisclosed** Jul 2006

An exit counts when it came after the firm's first round in the company. From historical deal records.

## The cheque

Growth Pre-seed Seed

Median round joined **$17M** the round, not its cheque Alone, median **$15M**

Led 0 of 33 rounds **0%**

- **Sole investor:** 2 rounds
- **Last cheque:** Oct 2014
- **Exits:** 6 from the portfolio

Rounds by stage said on their site

- Venture *8*
- Series B said *7*
- Series D *6*
- Series A said *6*
- Series C *4*
- Series E *1*
- Growth said *-*

Cheques by year Led Joined

2003 2014

Often in the room with

- [Investor AB](https://millionrounds.com/fund/investor-ab) 6
- [H.I.G. Capital](https://millionrounds.com/fund/h-i-g-capital) 5
- [Domain Associates](https://millionrounds.com/fund/domain-associates) 4
- [BDC Capital](https://millionrounds.com/fund/bdc-venture-capital) 3
- [CMEA Ventures](https://millionrounds.com/fund/cmea-capital) 3
- [Clarus Ventures](https://millionrounds.com/fund/blackstone) 3

**Pitching Thomas, McNerney & Partners?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Thomas, McNerney & Partners. A count of rooms they were both in, not a relationship either has claimed.

[**Investor AB** VC firm **6** rounds together](https://millionrounds.com/fund/investor-ab)[**H.I.G. Capital** Growth equity **5** rounds together](https://millionrounds.com/fund/h-i-g-capital)[**Domain Associates** VC firm **4** rounds together](https://millionrounds.com/fund/domain-associates)[**BDC Capital** VC firm **3** rounds together](https://millionrounds.com/fund/bdc-venture-capital)[**CMEA Ventures** VC firm **3** rounds together](https://millionrounds.com/fund/cmea-capital)[**Clarus Ventures** VC firm **3** rounds together](https://millionrounds.com/fund/blackstone)[**Quaker Partners** VC firm **3** rounds together](https://millionrounds.com/fund/quaker-partners)[**Venrock** VC firm **3** rounds together](https://millionrounds.com/fund/venrock)[**Accuitive Medical Ventures** VC firm **2** rounds together](https://millionrounds.com/fund/accuitive-medical-ventures)[**Deerfield** VC firm **2** rounds together](https://millionrounds.com/fund/deerfield)[**Genesys Capital** VC firm **2** rounds together](https://millionrounds.com/fund/genesys-capital)[**InterWest Partners** VC firm **2** rounds together](https://millionrounds.com/fund/interwest-partners)

## Quick answers about Thomas, McNerney & Partners

### What does Thomas, McNerney & Partners invest in?

Thomas, McNerney & Partners invests most often at Venture and Series B (47% of the rounds on record), in sectors such as Consumer, FinTech and Finance & Crypto.

### How active is Thomas, McNerney & Partners?

33 investments on record, 0 of them in the last 12 months. The most recent was in Oct 2014.

### How big are Thomas, McNerney & Partners's cheques?

The median round it joins is $17M.

### Does Thomas, McNerney & Partners lead rounds?

Rarely, if at all: none of its 33 investments on record names it as the lead.

### Where does Thomas, McNerney & Partners invest?

Most of the companies it backs are in the United States (100%).

### Is Thomas, McNerney & Partners investing now?

No investments in the last 12 months; the latest was in Oct 2014.

### Who does Thomas, McNerney & Partners invest alongside?

Most often Investor AB (6 rounds together), H.I.G. Capital (5 rounds together) and Domain Associates (4 rounds together).

### What kind of investor is Thomas, McNerney & Partners?

Thomas, McNerney & Partners is a VC firm based in Stamford, United States.

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=thomas-mcnerney-and-partners) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=thomas-mcnerney-and-partners)